You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Pulmonology

How Can FeNO Support the Management of Pediatric Asthma?

Dr. Michael Blaiss discusses the importance of measuring FeNO in pediatric asthma patients.

Michael Blaiss
FAAAAI, FACAAI, MD
Michael Blaiss

Learning objectives

  • Understand the utility of FeNO as a clinical biomarker involved in the management of pediatric severe asthma

Description

Michael Blaiss, MD, FACAAI, explores the utility of fractional exhaled nitric oxide (FeNO) as a clinical biomarker involved in the management of pediatric severe asthma.

MAT-US-2307270 v2.0 P - Exp. Date 08/31/2025

About this expert

Allergy/Immunology

Michael Blaiss

FAAAAI, FACAAI, MD

Clinical Professor of Pediatrics | Medical College of Georgia; Allergist | Good Samaritan Health Center of Gwinnett, Georgia, United States

See author’s profile
Michael Blaiss

Related resources